All About SCA2

Описание: SCA2 or Spinocerebellar Ataxia 2 is a rare neuromuscular disease. The National Ataxia Foundation is proud to host this webinar presented by Dr. Giulia Coarelli on July 11th, 2023. In "All About SCA2", she gave an overview of the causes and symptoms of the disease, the typical diagnostic journey for those affected, and what to expect for clinical care.

For more information on SCA2, register for our next webinar on Research and Treatment Development for SCA2 on July 26th at 9 am CDT: https://us02web.zoom.us/webinar/regis...

For more information on Ataxia, please visit our website: https://www.ataxia.org

Become a Free NAF member! https://bit.ly/JoinNAF

Follow us on Social Media!
NAF Facebook:   / ataxiafounda.  .
NAF Twitter:   / naf_ataxia  
NAF Instagram:   / ataxiafound.  .
Ataxia Subreddit:   / ataxia  

About the Speaker:

Dr. Giulia Coarelli is working as a neurologist at the Department of Genetics, Pitié-Salpêtrière University Hospital – Sorbonne University in Paris, and clinical investigator at the Paris Brain Institute (ICM), Paris, France. She has graduated with doctor of medicine degree at Sapienza University in Rome and she was resident in the Neurology Department at Sapienza University in Rome, Italy. After a research stay at the Paris Brain Institute during the Neurology Residency, she moved to Paris to continue her research at the ICM and she obtained the PhD degree in Neurosciences in the Alexandra Durr’s team. The main aim of her research is the identification of clinical, radiological and fluid biomarkers in spinocerebellar ataxias (SCAs). She uses multimodal assessments based on clinical scales, oculomotor recording, ophthalmological examination, neuropsychological evaluation, brain MRI, and blood and CSF analyses. A particular focus is to characterize the pre-Ataxic and early Ataxic phases that will be the target for potential future treatments.

About the Series:

NAF is producing a series of monthly educational webinars that focus on one type of Ataxia at a time. Each month we will feature a different type. Clinical experts will join us to take a look at the causes and symptoms of the disease, the typical diagnostic journey for those affected, and what to expect for clinical care. Research experts will teach us how the disease is studied and give an overview of the current state of research and drug development.